Literature DB >> 15614025

Association of peripheral and central arterial wave reflections with the CYP11B2 -344C allele and sodium excretion.

Wiktoria Wojciechowska1, Jan A Staessen, Katarzyna Stolarz, Tim Nawrot, Jan Filipovský, Milena Tichá, Giuseppe Bianchi, Eva Brand, Marcin Cwynar, Tomasz Grodzicki, Tatiana Kuznetsova, Harry A Struijker-Boudier, Vlasta Svobodová, Lutgarde Thijs, Luc M Van Bortel, Kalina Kawecka-Jaszcz.   

Abstract

OBJECTIVE: Angiotensin II and aldosterone, generated by the angiotensin-converting enzyme (ACE) and aldosterone synthase (CYP11B2), respectively, not only regulate sodium and water homeostasis, but also influence vascular remodeling in response to high blood pressure. In the European Project on Genes in Hypertension (EPOGH), we therefore investigated whether the ACE I/D and CYP11B2 C-344T polymorphisms influence early arterial wave reflections, a measure of vascular stiffness.
METHODS: We measured the peripheral and central augmentation index of systolic blood pressure by applanation tonometry at the level of the radial artery in 622 subjects (160 families and 64 unrelated individuals) randomly recruited from three European populations, whose average urinary sodium excretion ranged from 196 to 245 mmol/day. In multivariate analyses, with sodium excretion analyzed as a continuous variable, we explored the phenotype-genotype associations by means of generalized estimating equations and the quantitative transmission disequilibrium test.
RESULTS: The peripheral and central augmentation indexes were significantly higher in CYP11B2 -344C allele carriers than in -344T homozygotes. In offspring, early wave reflections increased with the transmission of the -344C allele. This effect of the CYP11B2 polymorphism occurred in subjects with a higher than median urinary sodium excretion (210 mmol/day). The ACE I/D polymorphism did not influence augmentation of systolic blood pressure.
CONCLUSIONS: The CYP11B2 C-344T polymorphism affects arterial stiffness. However, sodium intake seems to modulate this genetic effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15614025     DOI: 10.1097/00004872-200412000-00013

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Genetic determinants of arterial stiffness.

Authors:  Jeongok G Logan; Mary B Engler; Hyungsuk Kim
Journal:  J Cardiovasc Transl Res       Date:  2014-12-04       Impact factor: 4.132

2.  The impacts of the interaction of genetic variation, CYP11β2 and NEDD4L, with sodium intake on pediatric obesity with gender difference: a 3-year panel study.

Authors:  M Lee; D Y Kwon; J Park
Journal:  Int J Obes (Lond)       Date:  2016-12-26       Impact factor: 5.095

Review 3.  Salt controls endothelial and vascular phenotype.

Authors:  Kristina Kusche-Vihrog; Boris Schmitz; Eva Brand
Journal:  Pflugers Arch       Date:  2014-11-26       Impact factor: 3.657

Review 4.  A review of genetics, arterial stiffness, and blood pressure in African Americans.

Authors:  Jennifer L Hall; Daniel A Duprez; Ana Barac; Stephen S Rich
Journal:  J Cardiovasc Transl Res       Date:  2012-04-11       Impact factor: 4.132

5.  Aldosterone Synthase Promoter Polymorphism and Cardiovascular Phenotypes in a Large, Multiethnic Population-Based Study.

Authors:  James Brian Byrd; Richard J Auchus; Perrin C White
Journal:  J Investig Med       Date:  2015-10       Impact factor: 2.895

Review 6.  Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension.

Authors:  Paolo Palatini; Edoardo Casiglia; Jerzy Gąsowski; Jerzy Głuszek; Piotr Jankowski; Krzysztof Narkiewicz; Francesca Saladini; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Luc Van Bortel; Wiktoria Wojciechowska; Kalina Kawecka-Jaszcz
Journal:  Vasc Health Risk Manag       Date:  2011-12-07

7.  Arterial Stiffness Parameters Correlate with Estimated Cardiovascular Risk in Humans: A Clinical Study.

Authors:  Małgorzata Tąpolska; Maciej Spałek; Urszula Szybowicz; Remigiusz Domin; Karolina Owsik; Katarzyna Sochacka; Damian Skrypnik; Paweł Bogdański; Maciej Owecki
Journal:  Int J Environ Res Public Health       Date:  2019-07-17       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.